PR: WILEX AG: Subsidiary Heidelberg Pharma and Nordic Nanovector Enter into Collaboration to Develop Novel Antibody Drug Conjugates (ADC)
- PDF File: images/files/press-releases-and-ad-hoc-announcements/20161026_pm_cooperation-nordic-nanovector_eng_final.pdf
- Datum: Wednesday, 26 October 2016 12:48
- Erstellt am .
- Geändert am .
- Aufrufe: 1360